Transcriptional regulation of the transforming growth factor-beta2 gene in glioblastoma cells (Q40759126)

23 September 2017

Transcriptional regulation of the transforming growth factor-beta2 gene in glioblastoma cells (English)

1 reference

23 September 2017

1 reference

Kingsley-Kallesen M

1

1 reference

PubMed ID

11776974

23 September 2017

Luster TA

series ordinal

2

1 reference

PubMed ID

11776974

23 September 2017

Rizzino A

series ordinal

3

1 reference

23 September 2017

1 November 2001

1 reference

In Vitro Cellular & Developmental Biology - Animal

23 September 2017

1 reference

23 September 2017

37

1 reference

23 September 2017

684-690

1 reference

23 September 2017

10

1 reference

Phosphorylated CREB binds specifically to the nuclear protein CBP

23 September 2017

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Transcriptional activation of the type II transforming growth factor-beta receptor gene upon differentiation of embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Regulation of the transforming growth factor-beta 2 gene promoter in embryonal carcinoma cells and their differentiated cells: differential utilization of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Transcriptional regulation of the TGF-beta 2 gene in choriocarcinoma cells and breast carcinoma cells: differential utilization of Cis-regulatory elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Transforming growth factor-beta 2: cDNA cloning and sequence analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Sequence analysis of the promoter region of the glioblastoma derived T cell suppressor factor/transforming growth factor (TGF)-beta 2 gene reveals striking differences to the TGF-beta 1 and -beta 3 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Modulation of T-cell function by gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Cis-regulatory elements and transcription factors involved in the regulation of the transforming growth factor-beta 2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Transcription of the transforming growth factor-beta2 gene is dependent on an E-box located between an essential cAMP response element/activating transcription factor motif and the TATA box of the gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Calmodulin-dependent protein kinase II potentiates transcriptional activation through activating transcription factor 1 but not cAMP response element-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Regulation of activating transcription factor-1 and the cAMP response element-binding protein by Ca2+/calmodulin-dependent protein kinases type I, II, and IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Differential regulation of the transforming growth factor type-beta 2 gene promoter in embryonal carcinoma cells and their differentiated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Transcriptional regulation of the transforming growth factor-beta2 promoter by cAMP-responsive element-binding protein (CREB) and activating transcription factor-1 (ATF-1) is modulated by protein kinases and the coactivators p300 and CREB-binding pr

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

A simple phase-extraction assay for chloramphenicol acyltransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Transforming growth factor-beta: biological function and chemical structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Down-regulation of the cyclin A promoter by transforming growth factor-beta1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclic AMP-responsive element-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1290%2F1071-2690%282001%29037%3C0684%3ATROTTG%3E2.0.CO%3B2

Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation

21 January 2018

1 reference

12 December 2020

Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family

1 reference

12 December 2020

Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells

1 reference

12 December 2020

Growth regulatory factors and carcinogenesis: the roles played by transforming growth factor beta, its receptors and signaling pathways.

1 reference

12 December 2020

Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes

1 reference

12 December 2020

Transforming growth factor-beta.

1 reference

12 December 2020

Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

1 reference

12 December 2020

Identification of an activating transcription factor (ATF) binding site in the human transforming growth factor-beta 2 promoter

1 reference

12 December 2020

Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.

1 reference

12 December 2020

Protease inhibitors interfere with the transforming growth factor-beta-dependent but not the transforming growth factor-beta-independent pathway of tumor cell-mediated immunosuppression

1 reference

12 December 2020

Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice.

1 reference

12 December 2020

Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression

1 reference

12 December 2020

T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta

1 reference

12 December 2020

Induction of growth factor RNA expression in human malignant melanoma: markers of transformation

1 reference

12 December 2020

10.1290/1071-2690(2001)037<0684:TROTTG>2.0.CO;2

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

11776974